财新传媒
财新英文 > 要闻 > 正文

In Depth: China’s Pharma Pioneers in Africa Dig In for the Long Haul

By Xu Wen
2025年11月14日 18:10
Lured by a vast, underserved market, Chinese drug and medical device companies are learning that success in Africa requires more than just capital
Tuberculosis patient files at Machakos Teaching Referral Hospital in Kenya. Photo: Xu Wen/Caixin

(Nairobi, Kenya) — For Bai Jinkun, setting up a factory in the heart of Africa felt like a gamble with a one in 10 chance of paying off.

As general manager of Anhui Tiankang Medical Technology Co. Ltd.’s new plant in Rwanda, a landlocked nation on the East African Plateau, Bai oversaw every step of its creation, a journey he still recalls with wonder, and exhaustion. Just a few years ago, driven by a UNICEF tender that required local production, Bai took the plunge. Even with a guaranteed order, the obstacles were greater than he had ever imagined.

  [财新双语通产品,是为有双语需求读者专门订制的优惠产品, 按此可享超值优惠订阅。]

版面编辑:喻竹杨洋
财新网主编精选版电邮 样例
财新网新闻版电邮全新升级!财新网主编精心编写,每个工作日定时投递,篇篇重磅,可信可引。
订阅